Brooks John T, Kawwass Jennifer F, Smith Dawn K, Kissin Dmitry M, Lampe Margaret, Haddad Lisa B, Boulet Sheree L, Jamieson Denise J
MMWR Morb Mortal Wkly Rep. 2017 Aug 18;66(32):859-860. doi: 10.15585/mmwr.mm6632e1.
Existing U.S. guidelines recommend that men with human immunodeficiency virus (HIV) infection should achieve virologic suppression* with effective antiretroviral therapy (ART) before attempting conception (1). Clinical studies have demonstrated that effective ART profoundly reduces the risk for HIV transmission (2-4). This information might be useful for counseling couples planning a pregnancy in which the man has HIV infection and the woman does not (i.e., a mixed HIV-status couple, often referred to as a serodiscordant couple).
美国现行指南建议,感染人类免疫缺陷病毒(HIV)的男性在尝试受孕前应通过有效的抗逆转录病毒疗法(ART)实现病毒学抑制(1)。临床研究表明,有效的ART可大幅降低HIV传播风险(2 - 4)。这一信息可能有助于为男方感染HIV而女方未感染(即HIV感染状况不同的夫妇,通常称为血清学不一致夫妇)且计划怀孕的夫妇提供咨询。